Estimation of insulin-like growth factor-1 as a biomarker in nonalcoholic fatty liver disease in patients with metabolic syndrome

Estimation of insulin-like growth factor-1 as a biomarker in nonalcoholic fatty liver disease in patients with metabolic syndrome

Background Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver pathology especially in developed countries, ranging from simple liver steatosis to nonalcoholic steatohepatitis. Patients with NAFLD having metabolic syndrome have abnormal liver enzymes that positively co...

Full description

Bibliographic Details
Main Authors: Amal E El-Maghraby, Eman A Aissa, Hoda El H. Ahmed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Medicine in Scientific Research
Subjects:
igf-1
liver disease
metabolic syndrome
Online Access:http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2018;volume=1;issue=2;spage=73;epage=78;aulast=El-Maghraby

Internet

http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2018;volume=1;issue=2;spage=73;epage=78;aulast=El-Maghraby

Similar Items